Caribou Biosciences (CRBU) Current Leases (2022 - 2026)

Caribou Biosciences (CRBU) has 5 years of Current Leases data on file, last reported at $1.3 million in Q1 2026.

• Current Leases for Q1 2026 came in at $1.3 million, down 32.3% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.3 million (down 32.3% YoY), and the FY2025 annual result was $1.2 million, down 15.78% from the prior year.
• Current Leases grew to $1.3 million in Q1 2026 per CRBU's latest filing, from $1.2 million in the prior quarter.
• Over five years, Current Leases peaked at $2.7 million in Q3 2025 and troughed at $825000.0 in Q1 2022.
• A 5-year average of $1.3 million and a median of $1.2 million in 2023 frame the typical range for Current Leases.
• The sharpest annual moves came in 2025 and 2026: Current Leases surged 128.1% in 2025, then tumbled 32.3% in 2026.
• A 5-year view of Current Leases shows it stood at $966000.0 in 2022, then gained by 24.22% to $1.2 million in 2023, then rose by 18.83% to $1.4 million in 2024, then fell by 15.78% to $1.2 million in 2025, then advanced by 7.16% to $1.3 million in 2026.
• Business Quant data shows CRBU's Current Leases at $1.3 million in Q1 2026, $1.2 million in Q4 2025, and $2.7 million in Q3 2025.